F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
about
Clinical molecular imaging with radiotracers: current statusPET of HER2 Expression with a Novel 18FAl Labeled Affibody.Comparison of two peptide radiotracers for prostate carcinoma targetingGene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic NanocrystalsImaging tumor endothelial marker 8 using an 18F-labeled peptide.Protein and peptide probes for molecular imagingEvaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS.Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography ImagingQuantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.Molecular imaging of prostate cancer: PET radiotracers.N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis.Radiolabelled peptides for oncological diagnosis.Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN.A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [64 Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists.Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.Positron Emission Tomography Using a GRPR Antagonist (68)Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer.One-step radiosynthesis of 4-nitrophenyl 2-[(18) F]fluoropropionate ([(18) F]NFP); improved preparation of radiolabeled peptides for PET imaging.Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
P2860
Q26994741-D5395305-4907-42D7-8248-F4A9D91AF098Q33776692-F2283E0B-14F6-4C31-9A4E-0A5CA17773DBQ34167447-6097B028-5084-4BB4-A088-52FAA9A18F0DQ34381259-955C0586-48E0-445C-ACEA-4C79C122AF2FQ35436076-94D1E441-F45A-4035-9DC0-E38EBFB426AEQ35501293-3F8ACE2F-A341-4CC1-A555-9A186B748C3FQ36069546-D5512BF5-409F-4746-AB1F-5A71E5114525Q36072875-C1FD05A7-C3C2-4213-8E7D-937F2E481CEBQ36107186-F1CE4778-E97C-4777-8FFB-9608897A4843Q36129937-AB488D7E-60B1-457C-825D-B6A3B4BD8883Q36625118-B8C6E03C-134E-4703-A924-F4FF4AF85E7FQ36777292-8D31D5C1-8E22-4B59-9128-39BD80914D33Q37236103-9D4DA4BE-70F3-40C9-B434-4FF01851C3ECQ37592067-E9B33094-04D7-4B1F-8CD0-A0BC239D980FQ37724107-F18A7639-EE9E-4907-BB4C-E73950B14E59Q37990405-B976ABC8-EA9A-43B5-B0F8-1A5F2B25D9E3Q38826572-EED606E7-D272-4893-8209-A23F430F0D3DQ38842687-9C8EFFA1-569A-40BB-BF12-7E8AF6ADAF6CQ38891132-D19FC248-51CD-4B0B-B88F-2D3DFA00E4ACQ39004440-A200DEDA-8AAF-419E-BBEA-D94940AC1D53Q39015002-8A889E76-F456-4B65-B2E8-B72F2CC314B6Q39037392-10504F4C-7A93-4430-84EF-D8BC4BF72BDBQ39066397-A6EE23AC-305D-495D-BC07-2768F1C171A9Q48096316-7F43D5A4-4B27-4348-8981-9B2438E4A756Q48098858-01CB6E77-CFF1-4354-B01B-72C8B0650516Q48303231-AD27D0C0-5288-4E0C-A8BC-E0CD51B7BB20Q50076590-CAED4810-DE4A-4A03-A20F-03D2DD539192Q50083619-21034DAA-686E-41E4-B6C2-CEE96B9643B9Q50091264-663F1463-45B0-4EF2-8190-940F9186DF20Q53085688-269DF0AC-6D3F-4567-B12C-C0C0F1D3F15CQ54976417-7608CCCC-2080-4235-948B-017628CFE3B0
P2860
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@ast
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@en
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@nl
type
label
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@ast
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@en
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@nl
prefLabel
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@ast
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@en
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@nl
P2093
P2860
P356
P1433
P1476
F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.
@en
P2093
Haokao Gao
Lixin Lang
Qimeng Quan
Yongjun Yan
P2860
P304
P356
10.7150/THNO/V01P0220
P577
2011-01-01T00:00:00Z